These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18487089)

  • 1. Updates on pathogen inactivation of plasma using Theraflex methylene blue system.
    Seghatchian J; Walker WH; Reichenberg S
    Transfus Apher Sci; 2008 Jun; 38(3):271-80. PubMed ID: 18487089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the THERAFLEX UV-Platelets pathogen inactivation system - an update.
    Seghatchian J; Tolksdorf F
    Transfus Apher Sci; 2012 Apr; 46(2):221-9. PubMed ID: 22365926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience.
    Politis C; Kavallierou L; Hantziara S; Katsea P; Triantaphylou V; Richardson C; Tsoutsos D; Anagnostopoulos N; Gorgolidis G; Ziroyannis P
    Vox Sang; 2007 May; 92(4):319-26. PubMed ID: 17456156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma: 11 years' experience.
    Politis C; Kavallierou L; Hantziara S; Parara M; Zervou E; Katsarou O; Hatzitaki M; Fountouli P; Gioka A; Tzioura K; Koumarianos S; Asariotou M; Richardson C
    Transfus Med; 2014 Oct; 24(5):316-20. PubMed ID: 25262924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of methods of pathogen inactivation of FFP.
    Rock G
    Vox Sang; 2011 Feb; 100(2):169-78. PubMed ID: 20667071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
    Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
    Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
    Reichenberg S; Gravemann U; Sumian C; Seltsam A
    Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
    Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen reduction of blood components.
    Solheim BG
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.
    Seghatchian J; Struff WG; Reichenberg S
    Transfus Med Hemother; 2011; 38(1):55-64. PubMed ID: 21779206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
    Wang D; Bu F; Xu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
    Pock K; Heger A; Janisch S; Svae TE; Römisch J
    Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of the adsorbent CAA for hemopurification on normal components of human plasma in removing methylene blue].
    Ma Y; Xia Y; Yang X; Yu M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):311-3. PubMed ID: 12856607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma treated with methylene blue and light: clinical efficacy and safety profile.
    Lozano M; Cid J; Müller TH
    Transfus Med Rev; 2013 Oct; 27(4):235-40. PubMed ID: 24075476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of bacteria in plasma.
    Er AO; Chen J; Cesario TC; Rentzepis PM
    Photochem Photobiol Sci; 2012 Nov; 11(11):1700-4. PubMed ID: 22833174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
    Hellstern P
    Transfus Apher Sci; 2008 Aug; 39(1):69-74. PubMed ID: 18583192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of plasma proteins in whole blood-derived fresh frozen plasma prepared with three pathogen reduction technologies.
    Larrea L; Ortiz-de-Salazar MI; Martínez P; Roig R
    Transfus Apher Sci; 2015 Jun; 52(3):305-10. PubMed ID: 25656475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for neoantigens in human plasma after photochemical virus inactivation.
    Mohr H; Knüver-Hopf J; Lambrecht B; Scheidecker H; Schmitt H
    Ann Hematol; 1992 Nov; 65(5):224-8. PubMed ID: 1457580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.